Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle

被引:21
作者
delPozo, BF
PerezVizcaino, F
Fernandez, C
Zaragoza, F
Tamargo, J
机构
[1] UNIV COMPLUTENSE, SCH MED,CSIC,INST PHARMACOL & TOXICOL, DEPT PHARMACOL, E-28040 MADRID, SPAIN
[2] UNIV ALCALA DE HENARES, SCH PHARM, DEPT PHYSIOL & PHARMACOL, MADRID 28871, SPAIN
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1997年 / 29卷 / 04期
关键词
Na+ channel blocker; antiarrhythmic; rat aorta;
D O I
10.1016/S0306-3623(96)00517-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The vasorelaxant effects of seven NA(+) channel blockers (i.e., class I antiarrhythmic agents), quinidine, disopyramide, imipramine, lidocaine, mexiletine, flecainide, and desipramine, were investigated in isolated endothelium denuded rat aorta. 2. All drugs induced a concentration dependent relaxation in aorta precontracted with either 80 mM KCI or 10(-5) M noradrenaline and, with the exception of mexiletine, they were more potent in inhibiting KCl-induced contractions. 3. The degree of inhibition of high KCl-induced contractions produced by quinidine and desipramine increased with the time of depolarization. Furthermore, the inhibitory effect of quinidine also increased in aorta preincubated in 40 mM KCI, whereas the inhibitory effects of other antiarrhythmics were almost similar in 5 or 40 mM KCl solution. 4. In conclusion, all these class I antiarrhythmic drugs inhibited Ca2+ entry through voltage-and receptor-gated channels as well as Ca2+ release from intracellular stores. As a consequence, they decrease the availability of intracellular free Ca2+ required for vascular smooth muscle contraction. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 30 条
[1]  
BACHOUR G, 1977, DRUG DEV EVAL, V1, P39
[2]   CALCIUM CHANNELS IN MUSCLE-CELLS ISOLATED FROM RAT MESENTERIC-ARTERIES - MODULATION BY DIHYDROPYRIDINE DRUGS [J].
BEAN, BP ;
STUREK, M ;
PUGA, A ;
HERMSMEYER, K .
CIRCULATION RESEARCH, 1986, 59 (02) :229-235
[3]  
BURGES RA, 1987, J CARDIOVASC PHARM, V9, P110, DOI 10.1097/00005344-198701000-00018
[4]   VASCULAR ALPHA-ADRENERGIC BLOCKING PROPERTIES OF QUINIDINE [J].
CALDWELL, RW ;
ELAM, JT ;
MECCA, TE ;
NASH, CB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 94 (3-4) :185-192
[5]  
CAMPBELL TJ, 1989, HDB EXP PHARM, V89, P135
[6]   EFFECTS OF PROPAFENONE ON CA-45 MOVEMENTS AND CONTRACTILE RESPONSES IN VASCULAR SMOOTH-MUSCLE [J].
CARRON, R ;
PEREZVIZCAINO, F ;
DELPON, E ;
TAMARGO, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) :1453-1457
[7]   MECHANISMS OF CALCIUM ANTAGONIST-INDUCED VASODILATION [J].
CAUVIN, C ;
LOUTZENHISER, R ;
VANBREEMEN, C .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 :373-396
[8]   EFFECTS OF PROPAFENONE ON CALCIUM CURRENT IN GUINEA-PIG VENTRICULAR MYOCYTES [J].
DELGADO, C ;
TAMARGO, J ;
HENZEL, D ;
LORENTE, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :721-727
[9]  
DELPON E, 1991, N-S ARCH PHARMACOL, V344, P645
[10]   PROPAFENONE PREFERENTIALLY BLOCKS THE RAPIDLY ACTIVATING COMPONENT OF DELAYED RECTIFIER K+ CURRENT IN GUINEA-PIG VENTRICULAR MYOCYTES - VOLTAGE-INDEPENDENT AND TIME-DEPENDENT BLOCK OF THE SLOWLY ACTIVATING COMPONENT [J].
DELPON, E ;
VALENZUELA, C ;
PEREZ, O ;
CASIS, O ;
TAMARGO, J .
CIRCULATION RESEARCH, 1995, 76 (02) :223-235